2020 American Transplant Congress » Poster Session B: Liver: Hepatocellular Carcinoma and Other Malignancies

3:30pm-4:00pm

Bad Actors within Milan Criteria Undergoing OLT- Characterizing Their Pre-Transplant Tumor Behavior and Response to Locoregional Therapy

A. Mathur, E. Baughan, A. Griesemer, M. Najjar, O. Perez, A. Qian, T. Kato, J. Emond

3:30pm-4:00pm

Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-institutional Study Of > 3000 Patients

P. Tabrizian¹, M. Holzner², V. Agopian³, R. Busuttil³, G. Sapisochin⁴, N. Mehta⁵, F. Yao⁵, J. Roberts⁶, S. Florman¹, M. E. Schwartz¹, T. Ivanics⁷, J. Emond⁸, B. Samstein⁹, R. Brown, MD, MPH⁹, M. Najjar¹⁰, W. Chapman¹¹, M. Doyle¹¹, K. Halazun⁹

3:30pm-4:00pm

Hepatocellular Carcinoma Locoregional Therapy: A Comparison of Radiologic Treatment Response and Post-Transplant Pathology

A. J. Hargrove¹, T. Donovan², K. Fisher³, M. Goodenberger⁴, A. Langnas¹, S. Merani¹

3:30pm-4:00pm

Is the Survival Impacted by Multiple Cancer after Liver Transplantation? A Retrospective French National Multicentric Study between 1993-2013

M. Altieri

3:30pm-4:00pm

Liver Transplantation for Primary Liver Sarcoma in Children-The US Experience from the Scientific Registry for Transplant Recipients (1988-2018)

A. Amin, K. Soltys, S. Ranganathan, G. Bond, A. Khanna, A. Ganoza, Q. Sun, G. Mazariegos, R. Sindhi

3:30pm-4:00pm

Shorter Waiting Time Was Associated with Higher Risk of Recurrence of Hepatocellular Carcinoma in Liver Transplantation

T. Kitajima¹, S. Nagai¹, D. Moonka², S. Yeddula¹, O. Rizzo¹, M. Kavousi¹, R. Salgia², M. Rizzari¹, K. Collins¹, A. Yoshida¹, M. S. Abouljoud¹

3:30pm-4:00pm

Taking on Pediatric Liver Tumors – Beyond Hepatoblastoma

U. Ekong, N. Yazigi, K. Khan, S. Kaufman, J. Guerra, R. Girlanda, J. Hawksworth, A. Kroemer, C. Matsumoto, T. Fishbein

3:30pm-4:00pm

The Association of Body Weight Gain/Change and Hepatocellular Carcinoma Recurrence after Liver Transplant

O. Ahmed¹, M. Sauer¹, N. Vachharajani¹, S. H. Chang², Y. Park², A. S. Khan¹, W. C. Chapman¹, M. B. Doyle¹

3:30pm-4:00pm

The Impact of Initial Alpha-Fetoprotein >100 but <1,000 ng/mL and Pre-Transplant alpha-Fetoprotein Reduction on Outcomes after Liver Transplant in Patients with Hepatocellular Carcinoma

M. L. Goldman¹, K. Zhou², J. L. Dodge¹, F. Yao¹, N. Mehta¹

3:30pm-4:00pm

The Oncological Optimal Tacrolimus Target Level after Liver Transplant for Hepatocellular Carcinoma

K. Sasaki¹, J. McVey¹, D. Firl², Y. Inaba³, C. D. Kwon¹, K. Hashimoto¹, F. Aucejo¹